Northrop Guides 2027 Sales Growth of 5%-7% as Defense Demand Surges
NOC is trading near its 52-week low of $470.06 (14% above the low).
Summary
Northrop guided 2027 sales growth of 5% to 7% with every segment expanding, and said growth accelerates further beyond next year as franchise programs ramp, production rises and international sales build. That forward view is the new piece on top of this morning's third-quarter report. Q3 EPS of $7.89 beat the $7.18 consensus, sales rose 7% to $11.12 billion (just shy of the $11.14 billion estimate), and net awards of $16.4 billion pushed backlog to $109.6 billion. Aeronautics led with 14% sales growth and defense systems rose 12%, while mission and space managed only 2%. The stock is up 7% at $546.20, on pace for its biggest one-day gain in over a year. Full-year adjusted EPS guidance moved up to $29.35-$29.75 from $28.60-$29.10, with the sales range held at $43.75-$44.25 billion.
At the time of this announcement, NOC was trading at $537.43 on NYSE in the Manufacturing sector, with a market capitalization of approximately $76.3B. The 52-week trading range was $470.06 to $774.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.